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ABSTRACT  
This research work was aimed to enhance the oral bioavailability and provide faster onset of action of Prochlorperazine maleate (used for the 
treatment nausea and vomiting) by formulating its mouth dissolving film (MDF). Prochlorperazine belongs to BCS II and oral bioavailability of 
it’s about 11-15%. The MDF of Prochlorperazine  maleate was prepared by solvent casting  method using HPMC (film forming agent),Glycerol 
(plasticizer), Betacyclodextrin (solubilizing agent), Citric acid (saliva stimulating agent), Mannitol (sweetening agent). The formulation was 
optimized by two factors, three levels (32) was used for the formulation optimization of fast dissolving film of Prochlorperazine maleate and 
experimental trials are performed on all 9 formulation. In which the amount of HPMC, Glycerol were selected as independent variables (factor) 
varied at three different level: low (-1), medium (0), and high (+1) levels. The drug release and disintegration time used as dependent variables 
(response). and formulation was evaluated for weight variation, thickness, folding endurance, drug content, in- vitro disintegration, in vitro 
dissolution study and stability study. Based on results it was concluded that MDF (F3) showed enhanced bioavailability and faster onset of 
action. 
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INTRODUCTION 
The oral route is one of the most favoured routes of drug 
administration about 60% of all the formulations are solid 
dosage form. Tablet is the most preferred dosage form due to 
ease of transportation, as it is more suitable, cost effective, 
and ease of administration leads to high degree of patient 
compliance. However, peroral administration of drugs has 
demerits like liver degradation and enzymatic degradation 
within the gastrointestinal tract, that di sallow oral 
administration of various types of drugs especially peptides 
and proteins. Within the oral mucosal cavity, the buccal area 
seems to be one of the preferred routes for delivery of drug 
systemically. It provides benefits like prevention of hepatic 
first pass metabolism within the gastrointestinal tract, also 
provides improved enzyme flora for absorption of drugs [1]. 
Fast dissolving drug delivery system was developed in 1970s 
to beat swallowing problems linked with tablets and 
capsules for children and elderly sufferers. Oral mucosal 
drug delivery is vital route of drug administration. Several 
bioadhesive oral mucosal dosage forms have been invented, 
which includes mucoadhesive tablets, gels, ointments, 
patches, and the use of films for buccal delivery, also known 
as oral thin strips [1].  
Buccal cavity is made up of stratified squamous epithelium 
i.e separated from the lamina propria and sub mucosa. The 
penetrability of buccal mucosa is 4-4,000 times larger than 
the skin, and is less than that of the intestine. Therefore, the 
buccal delivery is an outstanding platform for absorption of 
molecules with poor skin penetration[2]. The prime obstacle 
to permeability in oral mucosa is the outcome of intercellular 
objects generated from the ‘membrane covering granules’ 
which is present at the topmost 200 μm layer. These oral film 
strips have a shelf life of 2-3 years, based on the active 
pharmaceutical ingredient but are tremendously responsive 
to environment humidity [2]. 
MATERIAL AND METHODS 
Materials: 
Prochlorperazine maleate was obtained as Yarrow chem. pvt. 
Ltd. HPMC, Glycerol, Betacyclodextrin, Mannitol,   Citric acid 
was obtained from loba chemicals. 
Methods: 
Preformulation Study 
Identification of Drug: 
When the drug Prochlorperazine maleate was examined in 
the range 220 nm to 360 nm, the 0.001% w/v solution in 
ethanol (95 percent) containing 0.01percent v/v of strong 
ammonia Solution shows an absorption maximum at 255 nm 
[3]. 
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Determination of Melting Point:  
Melting point of drug sample was determined by using 
melting point apparatus. Drug sample was taken and placed 
in a thin walled capillary tube; the tube was approximately 
10-12 cm in length with 1mm in diameter and closed at one 
end. The capillary was placed in melting point apparatus and 
gradually temperature rises when drug sample was melted 
the melting point of sample powder was recorded. 
Determination of solubility: 
Preparation of calibration curve of Prochlorperazine 
maleate:  
The calibration curves of Prochlorperazine maleate were 
prepared in distilled water and phosphate buffer pH 6.8 by 
using Shimadzu 1800 UV visible spectrophotometer. 
Accurately weighed 50 mg of Prochlorperazine maleate was 
transferred into a 50 ml volumetric flask and the volume was 
made up by using co solvent with distilled water to obtain a 
1000μg/ml stock solution of Prochlorperazine maleate. From 
the stock solution 1 ml was taken and transferred into a 10 
ml volumetric flask and rest of the volume was made up with 
solvent to obtain a 100μg/ml of solution from which further 
dilutions of 5, 10,15,20,25 µg/ml were prepared. Same 
procedure was followed for phosphate buffer pH 6.8 to 
prepare calibration curve[4]. 
Determination of solubility of Prochlorperazine maleate 
in various medium: 
The solubility of Prochlorperazine maleate in various 
medium was determined by equilibrium solubility method. 
In this method 5 ml of each solvent was taken into a separate 
vial and excess amount of Prochlorperazine maleate was 
added in to vials containing distilled water and phosphate 
buffer pH 6.8. The vials put on magnetic stirrer at 37±20C for 
12 hrs. The solutions were allowed to equilibrate for next 24 
h. The solution was transferred into eppendroff tubes and 
centrifuged for 5 min. at 2000 rpm. The supernatants of each 
vial were filter through 0.45micron membrane filter, make 
appropriate dilutions and analyzed by UV visible 
spectrophotometer (UV-1800 Shimadzu, japan ) at 255 nm, 
the studies was performed in triplicate[5]. 
Formulation of MDFs of Prochlorperazine maleate 
Mouth dissolving films were prepared by solvent casting 
method as per the composition shown in table 1.In this 
method, the required quantity of water soluble polymer 
HPMC was dissolved in distilled water in a beaker (covered 
with aluminium foil) with continuous stirring on magnetic 
stirrer to make required percentage of polymer solution and 
then the weighed quantity of ingredients like 
Prochlorperazine maleate as drug and like as drug and 
betacyclodextrin solid dispersion, glycerol as plasticizer, 
citric acid as saliva stimulating agent, Mannitol as 
Sweetening agent was dissolved in distilled water in another 
beaker and then this mixture was added to the polymer 
solution. After continuous stirring for 2 hours the solution 
was left undisturbed for 12 – 16 hours to remove all the air 
bubbles. This polymeric – drug solution was then poured on 
to the mould, allowed to air dry , packed in aluminum foil 
and then stored in desiccators until use. 
Drug-excipient interaction study: 
The compatibility of the drug was assessed by drug-excipient 
interaction study. The drug was mixed with various 
excipients in a 1:1 ratio in glass vials which were properly 
sealed and kept undisturbed at 40°C temperature for 14 
days. After 14 days incompatibility (if any) was confirmed by 
TLC[6]
 
Table 1. Formulation optimization of Mouth dissolving film 
BATCH NO.INGREDIENTS F1 F2 F3 F4 F5 F6 F7 F8 F9 
Drug+Betacyclodextrin solid 
dispersion 
40  40  40  40  40  40  40  40  40  
HPMC  (mg) 500 500 500 350 350 350 250 250 250 
Glycerol (ml) 0.05 0.1 0.075 0.05 0.1 0.075 0.05 0.1 0.075 
Citric acid  (mg) 20 20 20 20 20 20 20 20 20 
Mannitol (mg) 20 20 20 20 20 20 20 20 20 
Distilled water (ml) 10 10 10 10 10 10 10 10 10 
 
Evaluation of Mouth dissolving films: 
Weight of films: 
9 films were weighed on analytical balance and average 
weight was determined for each film. It is desirable that 
films should have nearly constant weight. It is useful to 
ensure that a film contains the proper amount of excipients 
and API.[7] 
Film thickness: 
The thickness of the film was measured by micrometer 
screw gauge (Acculab) at three different places; averages 
of three values were calculated. This is essential to 
ascertain uniformity in the thickness of the film this is 
directly related to the accuracy of dose in the film[8] 
Folding endurance: 
The folding endurance is expressed as the number of folds 
(number of times the film is folded at the same place, 
either to break the specimen or to develop visible cracks). 
This test is important to check the ability of the sample to 
withstand folding. This also gives an indication of 
brittleness. The folding endurance of the strips was 
determined by repeatedly folding one film at the same 
place till it broke. [8] 
Drug Content Uniformity: 
Drug content was determined by dissolving the prepared 
mouth dissolving film (MDF) of prochlorperazine maleate 
drug in 100 ml of phosphate buffer pH 6.8 .The aliquot of 
1ml was taken and diluted to 10ml with distilled water. 
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Then solution was filtered through whatman filter paper 
and solution was analyzed on UV spectrophotometer at 
desired wavelength to calculate the amount of drug 
present in the film.[9] 
In- vitro disintegration test: 
The in vitro disintegration study of the mouth dissolving 
film was carried out using 10 ml of water at 36⁰C and it 
was placed in a petridish of 10 cm diameter. Each MDF was 
carefully kept at the centre of the petridish and the time 
required for the MDF to completely disintegrate was noted. 
[10] 
In- vitro Dissolution test: 
The dissolution study of the Mouth dissolving film was 
determined in Electrolab Dissolution Apparatus type II 
following USP Paddle method. All tests were conducted in 
900 ml of Phosphate buffer pH 6.8. The dissolution 
medium was maintained at 37±0.5⁰C with paddle rotation 
speed at 50 rpm. Aliquot of 5ml was withdrawn at specific 
intervals and were immediately filtered through Whatman 
filter paper and analyzed spectrophotometrically. The 
absorbance values were transformed to concentration by 
reference to a standard calibration curve obtained 
experimentally measured on UV spectrophotometer[8]. 
Stability Studies 
Stability studies were conducted on prepared films to 
assess their stability with respect to their physical 
appearance, drug content and drug release characteristics 
after storing them at 40° C/65 % RH for 2 months. Samples 
were withdrawn at 0, 30, and 60 days.[11] 
RESULT AND DISCUSSION 
Identification of drug: 
The UV spectrum of Prochlorperazine maleate shows 
prominent absorbance maxima at wavelength 255 nm (fig 
No. 1.1) which is similar to the standard peaks therefore 
confirmed the identity of sample drug as Prochlorperazine 
maleate. Reported absorbance maxima were 
Prochlorperazine maleate were λmax at 255nm. 
 
Fig.No.1.1 UV Spectrum of Prochlorperazine 
maleate 
Preparation of calibration curves: The calibration 
curves of Prochlorperazine maleate in   various solvents 
e.g. Distilled water, 6.8 pH phosphate buffers were 
prepared. 
Table 2. Absorbance data of Prochlorperazine maleate 
in distilled water for preparation of calibration curve, 
at 255nm 
 
S. No. 
 
Concentration (µg/ml) 
 
Absorbance 
 
1 
 
5 
 
0.233 
 
2 
 
10 
 
0.454 
 
3 
 
15 
 
0.666 
 
4 
 
20 
 
0.902 
 
5 
 
25 
 
1.062 
 
 
 
 
 
Calibration curve of Prochlorperazine maleate in distilled water 255.0nm 
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Table 3. Absorbance data of Prochlorperazine maleate in phosphate buffer pH 6.8 for preparation of calibration curve, 
at 255 nm. 
 
S. No. 
 
Concentration (µg/ml) 
 
Absorbance 
 
1 
 
5 
 
0.220 
 
2 
 
10 
 
0.457 
 
3 
 
15 
 
0.762 
 
4 
 
20 
 
1.055 
 
5 
 
25 
 
1.247 
 
 
Calibration curve of Prochlorperazine maleate in pH 6.8 255.0nm 
Determination of solubility of Prochlorperazine maleate in various medium: 
The solubility of Prochlorperazine maleate in various medium was studied and the results of study were shown in below table 
Table 4. Solubility data of Prochlorperazine maleate different mediums 
S.No. Solvent 
 
Solubility (mg/ml) 
Mean±SD 
1 Distilled water 0.0138±0.03 
2 Phosphate buffer pH 6.8 1.152±0.00 
 
 Determination of solubility of Solid Dispersion: 
The solubility of inclusion complex in phosphate buffer pH 6.8 and distill water was studied and the results of study were 
shown in below table: 
Table 5. Solubility data of solid Dispersion: 
S.No.  Solvent 
 
Solubility (mg/ml) 
Mean±SD 
1 Distilled water  
Drug:β-CD (1:3) 
1.135±0.00 
2 Phosphate buffer pH 6.8 
Drug:β-CD (1:3) 
13.195±0.87 
 
Drug-excipient interaction study: The drug 
(Prochlorperazine maleate) was found to be compatible with 
various excipients which were selected for formulation of 
fast dissolving film. The compatibility was assessed by TLC 
and the retention factors of all ratios found similar. 
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Concentration ( µg/ml) 
Calibration curve of Prochlorperazine maleate in pH 6.8, phosphate 
buffer 
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Table 6: Data of drug-excipient interaction study: 
S.No. Drug/ drug+ 
Excipient Ratio      
(1:1) 
Physical 
appearance 
(initial) 
Present Day 
(Rf) 
Physical 
appearance 
(final) 
After15 
Days (Rf) 
Inference 
1. Drug 
(Prochlorperazine 
maleate) 
White 0.49 White 0.49 No Change 
2. Pure Drug + β-
Cyclodextrin 
White 0.51 White 0.53 No Change 
3. Pure Drug + HPMC Light brown 0.50 White 0.56 No Change 
4. Pure Drug + Glycerol White 0.48 White 0.49 No Change 
5. Pure Drug + Mannitol White 0.52 White 0.51 No Change 
6. Pure Drug+ Citric acid White 0.54 White 0.56 No Change 
 
Table 7 Evaluation data of Mouth dissolving film of prochlorperazine maleate 
Formulation Weight 
variation 
(mg) 
Mean±SD 
Thickness 
(mm) 
Mean±SD 
Folding 
endurance 
(Times) 
 
Drug Content 
(%) 
 
Disintegration 
Time 
(sec) 
Mean±SD 
F1 48.9±0.02 0.1±0.07 142 85.1 36 
F2 34.5±0.05 0.08±0.04 126 86.6 30 
F3 29.8±0.04 0.09±0.02 151 97.4 18 
F4 31±0.06 0.07±0.08 124 86.6 20 
F5 39±0.04 0.09±0.4 141 93 31 
F6 49±0.09 0.1±0.09 130 92.2 35 
F7 34±0.08 0.09±0.06 137 92.3 36 
F8 47.8±0.05 0.08±0.07 145 87.7 32 
F9 35±0.07 0.07±0.05 140 86.4 35 
 
 
Stability studies 
The result of stability study indicated that the drug 
product falls well within the proposed stability 
specification. The data showed that there is no significant 
physical or chemical change indicating that the 
formulation would maintain its efficacy and quality 
throughout its proposed shelf life. 
CONCLUSION 
In the present research work an attempt has been made to 
optimized, formulate and evaluate Mouth dissolving film of 
Prochlorperazine maleate. Prochlorperazine maleate is a 
antiemetic drug belongs to BCS class-II (Low Solubility and 
high permeability). It has poor bioavailability and low 
solubility. In the present work solubility and bioavailability 
of drug was enhanced using inclusion complex. The 
inclusion  
 
 
 
complex of Drug: β-cyclodextrin was prepared in different 
ratio by physical mixture method. The solvent casting 
method was used to formulate and evaluate fast dissolving 
film of Prochlorperazine maleate. Addition of Drug: β-
cyclodextrin inclusion complex leads to improve the 
dissolution characteristics and solubility of drug at 
optimum concentration (1:3). So, considering the above 
results it was found that the formulation F3was found to 
be optimized formulation from the data obtained. It is 
observed from the formulation F3 which shown 
disintegration time 18 sec. and percentage cumulative 
drug release shown 96.39% within 180 second. Thus, it 
can be concluded that the drug given in the form of fast 
dissolving films should be advantageous for patients 
suffering from nausea and vomiting, providing better 
patient compliance and an effective mode of treatment. 
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